- Home
- CAH vs LVS Comparison
CAH vs LVS Comparison
Compare CAH & LVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- LVS
- Stock Information
- Founded
- CAH 1979
- LVS 1988
- Country
- CAH United States
- LVS United States
- Employees
- CAH N/A
- LVS N/A
- Industry
- CAH Other Pharmaceuticals
- LVS Hotels/Resorts
- Sector
- CAH Health Care
- LVS Consumer Discretionary
- Exchange
- CAH Nasdaq
- LVS Nasdaq
- Market Cap
- CAH 39.9B
- LVS 34.2B
- IPO Year
- CAH N/A
- LVS 2004
- Fundamental
- Price
- CAH $157.12
- LVS $52.44
- Analyst Decision
- CAH Buy
- LVS Buy
- Analyst Count
- CAH 15
- LVS 15
- Target Price
- CAH $154.67
- LVS $57.50
- AVG Volume (30 Days)
- CAH 1.9M
- LVS 5.5M
- Earning Date
- CAH 08-12-2025
- LVS 07-23-2025
- Dividend Yield
- CAH 1.30%
- LVS 1.91%
- EPS Growth
- CAH 155.27
- LVS N/A
- EPS
- CAH 6.38
- LVS 1.97
- Revenue
- CAH $222,286,000,000.00
- LVS $11,615,000,000.00
- Revenue This Year
- CAH N/A
- LVS $5.22
- Revenue Next Year
- CAH $11.29
- LVS $5.86
- P/E Ratio
- CAH $24.63
- LVS $26.60
- Revenue Growth
- CAH 0.86
- LVS 1.62
- 52 Week Low
- CAH $96.05
- LVS $30.18
- 52 Week High
- CAH $168.44
- LVS $56.61
- Technical
- Relative Strength Index (RSI)
- CAH 41.19
- LVS 75.54
- Support Level
- CAH $156.09
- LVS $47.97
- Resistance Level
- CAH $162.25
- LVS $50.35
- Average True Range (ATR)
- CAH 2.52
- LVS 1.12
- MACD
- CAH -0.97
- LVS -0.01
- Stochastic Oscillator
- CAH 8.60
- LVS 98.67
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About LVS Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.